Align TechnologySTU:AFW +1.45%90 EV-to-FCF is 20.89 as of Jul. 12, 2026, which is 54% below its 10-year median of 45.21. GuruFocus rates STU:AFW with a GF Score™ of 90/100 and a GF Value™ of €208.15 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 416 Medical Devices & Instruments companies, Align Technology ranks better than 55.53% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Align Technology's Enterprise Value is €10,464 Mil.
Align Technology's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €501 Mil. Therefore, Align Technology's EV-to-FCF for today is 20.89.
The historical rank and industry rank for Align Technology's EV-to-FCF or its related term are showing as below:
STU:AFW'
s EV-to-FCF Range Over the Past 10 Years
Min: 13.27 Med: 45.21 Max: 118.6
Current: 20.42
During the past 13 years, the highest EV-to-FCF of Align Technology was 118.60. The lowest was 13.27. And the median was 45.21.
STU:AFW's EV-to-FCF is ranked better than 55.53% of 416
companies
in the Medical Devices & Instruments industry
Industry Median: 23.355
vs STU:AFW: 20.42
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Align Technology's PE Ratio (TTM) for today is calculated as:
Align Technology's share price for today is €157.80.
Align Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €5.128.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Align Technology EV-to-FCF Related Terms
Align Technology EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Align Technology's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Align Technology's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Align Technology EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Align Technology's EV-to-FCF falls into.
Align Technology's current Enterprise Value is €10,464 Mil.
Align Technology's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €501 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Align Technology (STU:AFW) has a EV-to-FCF of 20.89 as of Jul. 12, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Align Technology and its competitors. This is 54% below median its historical median of 45.21. Over the past decade, Align Technology's EV-to-FCF has ranged from 13.27 to 118.60. According to the industry distribution chart, Align Technology ranks #185 out of 416 companies in the Medical Devices & Instruments industry, placing it in the top 44.5%.
Is Align Technology's EV-to-FCF too high?
Align Technology's current EV-to-FCF of 20.89 is 54% below median its 10-year median of 45.21. Over the past 10 years, this metric has ranged from a low of 13.27 to a high of 118.60. The Medical Devices & Instruments industry median EV-to-FCF is 23.36. Align Technology's value of 20.89 is 10.6% below this industry median. Based on the distribution chart, Align Technology ranks #185 out of 416 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Align Technology has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Align Technology's EV-to-FCF compare to SOLV and COO?
According to the Medical Devices & Instruments industry distribution chart, Align Technology ranks #185 out of 416 companies for EV-to-FCF. This puts Align Technology in the upper half of its industry. The industry median EV-to-FCF is 23.36. Align Technology's value of 20.89 is 10.6% below this benchmark. Historically, Align Technology's own EV-to-FCF has ranged from 13.27 to 118.60 over the past decade. While the company's 10-year median is 45.21 vs. the industry median of 23.36, Align Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.36, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Align Technology's current EV-to-FCF of 20.89 is 10.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Align Technology and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Align Technology's current EV-to-FCF is 20.89, which is 54% below median its own 10-year median of 45.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Align Technology stock overvalued right now?
Based on GuruFocus' analysis, Align Technology (STU:AFW) is currently considered Modestly Undervalued. The stock's GF Value™ is €208.15, compared to a current price of €157.80 — trading 24.2% below its estimated fair value. The current EV-to-FCF is 20.89, which is 54% below median its 10-year median of 45.21 and 10.6% below the Medical Devices & Instruments industry median of 23.36. Align Technology's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Align Technology (STU:AFW), the current EV-to-FCF is 20.89 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Align Technology (STU:AFW) Overvalued in 2026?
Based on GuruFocus' analysis, Align Technology stock appears to be undervalued.
The current stock price of €157.80 is trading 24.2% below its estimated GF Value™ of €208.15.
GuruFocus considers Align Technology to be Modestly Undervalued.
Key valuation signals for STU:AFW:
EV-to-FCF: 20.89 (54% below median its 10-year median of 45.21)
GF Value™: €208.15 vs. price of €157.80 (24.2% below fair value)
Industry Position: 10.6% below the Medical Devices & Instruments median (#185 of 416)
No single metric tells the full story. See the STU:AFW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
90GF Score
Get the complete analysis for STU:AFW
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:AFW has been successfully added to your 
